Your Unread Messages in Pharma News
See All >> Messages include industry-sponsored communications and special communications from MDLinx861 GlaxoSmithKline supports the establishment of "Improving Health for Ohioans" month Full Text GlaxoSmithKline, February 23, 2006
862 AstraZeneca U.S. Donates $500,000 to United Way of Delaware; Gift Will Support United Ways Healthy Delawareans Fund Full Text AstraZeneca, February 17, 2006
863 Twin Cities Marathon And Medtronic Join To Support World-Class Running Events And Community Health Initiatives Full Text Medtronic, February 16, 2006
864 Superior e-Detailing proves a winner in influencing Medical Community Full Text PharmiWeb, February 14, 2006
865 Gilead Sciences Launches Stop Hep B Campaign; Initiative Aims to Combat Chronic Hepatitis B by Educating and Empowering At-Risk Communities Full Text Gilead, February 13, 2006
866 Merck Launches New Consumer Health Resource, Guide to Affordable Medicine Full Text Merck, February 8, 2006
867 National Black HIV/AIDS Awareness and Information Day 2006 Full Text NIH News, February 7, 2006
868 Guidant Updates Worldwide Physician Communication Regarding Important Safety Information About Certain Pacemakers Full Text Boston Scientific, January 24, 2006
869 NICE (National Institute for Health and Clinical Excellence) review of treatments for Alzheimer’s disease Full Text Shire Pharmaceuticals, January 23, 2006
870 CDC Announces Change in Recommendations for use of Antivirals; Clinicians Should Not Prescribe Two Common Antivirals Full Text CDC, January 16, 2006
871 Parents Unite to Fight Childhood Episodes of Sudden Cardiac Arrest Full Text Medtronic, January 11, 2006
872 Initial Results Help Clinicians Identify Patients With Treatment-Resistant Depression Full Text NIH News, January 4, 2006
873 Consumers find some pharma ads memorable and motivating Full Text eyeforpharma, December 8, 2005
1 U.S. FDA Approves INVOKANA (Canagliflozin) to Treat Adults with Type 2 Diabetes Janssen, April 1, 2013 Free full text
2 Will "Robust Pipeline" Yield More New Drugs? Applied Clinical Trials, January 22, 2013 Free full text
3 Phase III results: tiotropium Respimat is effective in symptomatic asthma patients irrespective of their allergic status Boehringer Ingelheim, March 1, 2013 Free full text
4 Sarepta Therapeutics Announces a Continued Benefit on Walking Test Through 62 Weeks in Phase IIb Open-Label Extension Study of Eteplirsen in Duchenne Muscular Dystrophy Sarepta Therapeutics, March 4, 2013 Free full text
5 The Nutrition Facts Label: Helping Americans Make Heart-Healthy Choices FDA Press Announcements, February 8, 2013 Free full text
6 Regular vitamin C supplementation does little for incidence of colds Formulary , March 19, 2013 Free full text
7 Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study Human Reproduction, April 23, 2013
8 Trends and Demographics in Hip Arthroscopy in the United States Arthroscopy, February 15, 2013 Review Article
9 Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan International Journal of Clinical Oncology, April 10, 2013
Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close